协调的转录与分解代谢程序支持胰腺癌对RAS-MAPK通路抑制的铁依赖性适应
本研究探讨胰腺导管腺癌(PDA)细胞对RAS-MAPK信号药理学抑制的代谢适应机制。使用MEK抑制剂曲美替尼处理PDA细胞,通过转录组和染色质免疫沉淀分析发现c-MYC与溶酶体基因表达主转录因子MiT/TFE蛋白之间的转录拮抗。MEKi导致c-MYC下调并增加MiT/TFE依赖的溶酶体生物发生,定量蛋白质组学揭示MEKi处理细胞依赖铁蛋白自噬,促进线粒体铁硫簇蛋白合成和线粒体呼吸增强。抑制铁利用使PDA细胞对MEKi敏感,提示适应KRAS-MAPK抑制过程中对溶酶体依赖铁供应的关键可靶向依赖性。
要点
- MEK抑制剂曲美替尼处理PDA细胞导致c-MYC下调并增加MiT/TFE依赖的溶酶体生物发生。
- MEKi处理细胞依赖铁蛋白自噬以促进线粒体铁硫簇蛋白合成和增强线粒体呼吸。
- 抑制铁利用使PDA细胞对MEKi敏感,破坏铁蛋白自噬与KRAS-MAPK抑制协同并阻止PDA生长。
核心结论
- MAPK通路抑制后c-MYC水平降低促进自噬和溶酶体生物发生上调,增加的自噬-溶酶体活性是铁蛋白自噬介导的铁供应所必需的,支持治疗应激下的线粒体呼吸。
- 破坏铁蛋白自噬与KRAS-MAPK抑制协同并阻止PDA生长,突显关键可靶向的代谢依赖性。
研究设计与样本
- 使用MEK抑制剂曲美替尼处理PDA细胞,进行转录组和染色质免疫沉淀分析。
- 对PDA细胞或患者类器官进行MEKi处理,并开展免疫纯化溶酶体的定量蛋白质组学。
主要发现
- 基线条件下c-MYC和MiT/TFE因子竞争结合溶酶体基因启动子以精细调节基因表达。
- MEKi处理PDA细胞或患者类器官导致c-MYC下调和MiT/TFE依赖的溶酶体生物发生增加。
- 免疫纯化溶酶体的定量蛋白质组学揭示MEKi处理细胞依赖铁蛋白自噬。
- 铁蛋白自噬促进线粒体铁硫簇蛋白合成和增强线粒体呼吸。
- 抑制铁利用使PDA细胞对MEKi敏感。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The mechanisms underlying metabolic adaptation of pancreatic ductal adenocarcinoma (PDA) cells to pharmacologic inhibition of RAS-MAPK signaling are largely unknown. Using transcriptome and chromatin immunoprecipitation profiling of PDA cells treated with the MEK inhibitor (MEKi) trametinib, we identify transcriptional antagonism between c-MYC and the master transcription factors for lysosome gene expression, the MiT/TFE proteins. Under baseline conditions, c-MYC and MiT/TFE factors compete for binding to lysosome gene promoters to fine-tune gene expression. Treatment of PDA cells or patient organoids with MEKi leads to c-MYC downregulation and increased MiT/TFE-dependent lysosome biogenesis. Quantitative proteomics of immunopurified lysosomes uncovered reliance on ferritinophagy, the selective degradation of the iron storage complex ferritin, in MEKi-treated cells. Ferritinophagy promotes mitochondrial iron-sulfur cluster protein synthesis and enhanced mitochondrial respiration. Accordingly, suppressing iron utilization sensitizes PDA cells to MEKi, highlighting a critical and targetable reliance on lysosome-dependent iron supply during adaptation to KRAS-MAPK inhibition. SIGNIFICANCE: Reduced c-MYC levels following MAPK pathway suppression facilitate the upregulation of autophagy and lysosome biogenesis. Increased autophagy-lysosome activity is required for increased ferritinophagy-mediated iron supply, which supports mitochondrial respiration under therapy stress. Disruption of ferritinophagy synergizes with KRAS-MAPK inhibition and blocks PDA growth, thus highlighting a key targetable metabolic dependency. See related commentary by Jain and Amaravadi, p. 2023. See related article by Santana-Codina et al., p. 2180. This article is highlighted in the In This Issue feature, p. 2007.
引用
- Ravichandran M, Hu J, Cai C, et al. Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in Pancreatic Cancer. Cancer Discov. 2022. PMID: 35771494. doi:10.1158/2159-8290.CD-22-0044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。